Sigma Genetics

About

Sigma Genetics develops devices that can deliver DNA, RNA, and other charged molecules into cells by using magnetic fields. When compared to conventional electroporation, this technique has several key advantages, which include: the absence of arcing, the ability to scale, and the benefit of being non-invasive for in vivo applications. This platform technology can be applied to a wide range of applications- cell therapies, cancer drug delivery, DNA vaccines, biopharma manufacturing, and cosmetics.

Founders

Karen EatonFounder/CEO

Highly motivated to advance the healthcare field and I aspire to use both my business skills and scientific background to forward the medical industry. Interested in all things bio: cell/gene therapy, computational enzyme design, immunology, diagnostics, health devices, and so much more.

LinkedIn Twitter

Matthew ScholzFounder

Matthew is a serial entrepreneur with a background in gene therapy and computer security. He has founded or co-founded five biotechnology companies and has played an integral role in the development of several advanced therapeutics, including three first-in-class treatment modalities. He is the author of dozens of patents covering innovations ranging from novel transfection technologies, immune cell programming, in vivo production of therapeutic proteins, senolytics, longevity, and oncology.

Chris PihlFounder